Company News
3G Biotech signed agreement with Qilu pharmaceutical company for testing UGT1A1.
Time：2012-03-15 14:42:00 Source：3G Biotech Readers：
3G Biotech signed agreement with Qilu pharmaceutical company, to offer services of testing UGT1A1 gene of cancer patients, in order to implement personalinzed therapy for Irinotican on May15th,2012.
Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs and active pharmaceutical ingredients in the therapeutic areas of Oncology, Cerebrovascular & Cardiovascular, Infections, Psychological and Neurological System, Respiratory System, Ophthalmological Diseases, etc.
Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs and active pharmaceutical ingredients in the therapeutic areas of Oncology, Cerebrovascular & Cardiovascular, Infections, Psychological and Neurological System, Respiratory System, Ophthalmological Diseases, etc.
